vs

Side-by-side financial comparison of INDEPENDENT BANK CORP (INDB) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $212.5M, roughly 1.1× INDEPENDENT BANK CORP). INDEPENDENT BANK CORP runs the higher net margin — 35.5% vs 19.4%, a 16.1% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 46.9%). INDEPENDENT BANK CORP produced more free cash flow last quarter ($75.5M vs $34.8M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 24.3%).

Independent Bank is a bank headquartered in Grand Rapids, Michigan. The bank has 62 branches, all of which are in Michigan.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

INDB vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.1× larger
ORGO
$225.6M
$212.5M
INDB
Growing faster (revenue YoY)
ORGO
ORGO
+31.2% gap
ORGO
78.1%
46.9%
INDB
Higher net margin
INDB
INDB
16.1% more per $
INDB
35.5%
19.4%
ORGO
More free cash flow
INDB
INDB
$40.8M more FCF
INDB
$75.5M
$34.8M
ORGO
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
24.3%
INDB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INDB
INDB
ORGO
ORGO
Revenue
$212.5M
$225.6M
Net Profit
$75.3M
$43.7M
Gross Margin
Operating Margin
28.1%
Net Margin
35.5%
19.4%
Revenue YoY
46.9%
78.1%
Net Profit YoY
50.6%
469.5%
EPS (diluted)
$1.51
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INDB
INDB
ORGO
ORGO
Q4 25
$212.5M
$225.6M
Q3 25
$203.3M
$150.9M
Q2 25
$147.5M
$101.0M
Q1 25
$145.5M
$86.7M
Q4 24
$144.7M
$126.7M
Q3 24
$141.7M
$115.2M
Q2 24
$137.9M
$130.2M
Q1 24
$137.4M
$110.0M
Net Profit
INDB
INDB
ORGO
ORGO
Q4 25
$75.3M
$43.7M
Q3 25
$34.3M
$21.6M
Q2 25
$51.1M
$-9.4M
Q1 25
$44.4M
$-18.8M
Q4 24
$50.0M
$7.7M
Q3 24
$42.9M
$12.3M
Q2 24
$51.3M
$-17.0M
Q1 24
$47.8M
$-2.1M
Gross Margin
INDB
INDB
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Q1 24
73.9%
Operating Margin
INDB
INDB
ORGO
ORGO
Q4 25
28.1%
Q3 25
21.8%
13.7%
Q2 25
44.6%
-12.5%
Q1 25
39.3%
-30.9%
Q4 24
8.1%
Q3 24
39.0%
5.4%
Q2 24
48.1%
-10.7%
Q1 24
45.5%
-3.5%
Net Margin
INDB
INDB
ORGO
ORGO
Q4 25
35.5%
19.4%
Q3 25
16.8%
14.3%
Q2 25
34.6%
-9.3%
Q1 25
30.5%
-21.7%
Q4 24
34.6%
6.1%
Q3 24
30.3%
10.7%
Q2 24
37.2%
-13.1%
Q1 24
34.8%
-1.9%
EPS (diluted)
INDB
INDB
ORGO
ORGO
Q4 25
$1.51
$0.31
Q3 25
$0.69
$0.11
Q2 25
$1.20
$-0.10
Q1 25
$1.04
$-0.17
Q4 24
$1.18
$0.05
Q3 24
$1.01
$0.09
Q2 24
$1.21
$-0.13
Q1 24
$1.12
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INDB
INDB
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$3.6B
$300.1M
Total Assets
$24.9B
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INDB
INDB
ORGO
ORGO
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Q1 24
$88.6M
Total Debt
INDB
INDB
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
INDB
INDB
ORGO
ORGO
Q4 25
$3.6B
$300.1M
Q3 25
$3.5B
$255.1M
Q2 25
$3.1B
$233.2M
Q1 25
$3.0B
$242.9M
Q4 24
$3.0B
$262.9M
Q3 24
$3.0B
$278.5M
Q2 24
$2.9B
$263.5M
Q1 24
$2.9B
$278.0M
Total Assets
INDB
INDB
ORGO
ORGO
Q4 25
$24.9B
$598.7M
Q3 25
$25.0B
$509.8M
Q2 25
$20.0B
$461.1M
Q1 25
$19.9B
$467.4M
Q4 24
$19.4B
$497.9M
Q3 24
$19.4B
$446.3M
Q2 24
$19.4B
$443.2M
Q1 24
$19.3B
$458.5M
Debt / Equity
INDB
INDB
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INDB
INDB
ORGO
ORGO
Operating Cash FlowLast quarter
$78.9M
$39.4M
Free Cash FlowOCF − Capex
$75.5M
$34.8M
FCF MarginFCF / Revenue
35.5%
15.4%
Capex IntensityCapex / Revenue
1.6%
2.1%
Cash ConversionOCF / Net Profit
1.05×
0.90×
TTM Free Cash FlowTrailing 4 quarters
$239.0M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INDB
INDB
ORGO
ORGO
Q4 25
$78.9M
$39.4M
Q3 25
$52.2M
$3.1M
Q2 25
$106.7M
$-32.9M
Q1 25
$13.3M
$-19.9M
Q4 24
$42.9M
$10.9M
Q3 24
$70.2M
$8.7M
Q2 24
$65.6M
$4.7M
Q1 24
$51.1M
$-10.2M
Free Cash Flow
INDB
INDB
ORGO
ORGO
Q4 25
$75.5M
$34.8M
Q3 25
$49.7M
$844.0K
Q2 25
$102.5M
$-36.5M
Q1 25
$11.3M
$-23.6M
Q4 24
$36.5M
$7.6M
Q3 24
$64.4M
$6.1M
Q2 24
$61.9M
$2.9M
Q1 24
$46.7M
$-12.4M
FCF Margin
INDB
INDB
ORGO
ORGO
Q4 25
35.5%
15.4%
Q3 25
24.4%
0.6%
Q2 25
69.5%
-36.1%
Q1 25
7.8%
-27.2%
Q4 24
25.2%
6.0%
Q3 24
45.4%
5.3%
Q2 24
44.9%
2.2%
Q1 24
34.0%
-11.3%
Capex Intensity
INDB
INDB
ORGO
ORGO
Q4 25
1.6%
2.1%
Q3 25
1.2%
1.5%
Q2 25
2.9%
3.6%
Q1 25
1.4%
4.2%
Q4 24
4.4%
2.7%
Q3 24
4.1%
2.2%
Q2 24
2.7%
1.4%
Q1 24
3.2%
2.0%
Cash Conversion
INDB
INDB
ORGO
ORGO
Q4 25
1.05×
0.90×
Q3 25
1.52×
0.14×
Q2 25
2.09×
Q1 25
0.30×
Q4 24
0.86×
1.43×
Q3 24
1.64×
0.71×
Q2 24
1.28×
Q1 24
1.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons